Infinity Pharmaceuticals Management Discusses Q1 2013 Results – Earnings …

Published May 12, 2013

Infinity Pharmaceuticals Management Discusses Q1 2013 Results – Earnings …
Filed under: dual diagnosis treatment program

We're continuing to make considerable progress with our lead product candidate, IPI-145, which was recently granted an orphan drug designation by both the FDA and EMA for the treatment of CLL and SLL. Our Phase I trial of IPI-145 in … In addition to …
{Source}

Hillsboro School District names new principals at middle schools and elementary
Filed under: dual diagnosis treatment program

In 2010, she moved to her current position as vice principal of Day and Residential Treatment schools in the Portland Public School District. She is also program director for the district's Teen Parent Services program. Mike Strande will take the helm …
{Source}